Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis

Published:2019-12-17 Issue: Volume:7 Page:
ISSN:2296-4185
Container-title:Frontiers in Bioengineering and Biotechnology
language:
Short-container-title:Front. Bioeng. Biotechnol.

Author:

Velino Cecilia,Carella Francesca,Adamiano Alessio,Sanguinetti Maurizio,Vitali Alberto,Catalucci Daniele,Bugli Francesca,Iafisco Michele

Funder

Fondazione per la Ricerca sulla Fibrosi Cistica

Publisher

Frontiers Media SA

Subject

Biomedical Engineering,Histology,Bioengineering,Biotechnology

Reference228 articles.

1. The nephropathy of cystic fibrosis: a human model of chronic nephrotoxicity;Abramowsky;Hum. Pathol.,1982

2. Inhaled therapy in cystic fibrosis: agents, devices and regimens;Agent;Breathe,2015

3. Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying;Agnoletti;Eur. J. Pharm. Biopharm.,2017

4. Synthesis and immunological evaluation of a nanovaccine based on PLGA nanoparticles and alginate antigen against infections caused by Pseudomonas aeruginosa;Alikhani;Biomed. Phys. Eng. Express,2018

5. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains;Alipour;Int. J. Pharm.,2008

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-enabled delivery of diosgenin and emodin ameliorates respirable silica dust-induced pulmonary fibrosis silicosis in rats;Ecotoxicology and Environmental Safety;2024-07

2. Nanomedicines via the pulmonary route: a promising strategy to reach the target?;Drug Delivery and Translational Research;2024-04-08

3. Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives;Journal of Drug Delivery Science and Technology;2024-04

4. State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives;Pharmaceutics;2024-03-01

5. Nanoparticle-based platforms for targeted drug delivery to the pulmonary system as therapeutics to curb cystic fibrosis: A review;Journal of Microbiological Methods;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3